Afatinib Dimaleate
規格
850140-73-7CAS番号
810-416-1EC番号
bis((Z)-but-2-enedioic acid);(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamideIUPAC名
C32H33ClFN5O11化学式
718.1 g/mol分子量
AFATINIB DIMALEATE; 850140-73-7; Gilotrif; Afatinib maleate; Giotrif; BIBW 2992MA2; BIBW2992 MA2; BIBW2992-MA2; V1T5K7RZ0B; BIBW-2992MA2; BIBW-2992 MA2; BIBW-2992-MA2; CHEBI:76003; DTXSID701027713; RefChem:56996; BIBW 2992 MA2; DTXCID001513290; (2E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide bis(hydrogen (2Z)-but-2-enedioate); 2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)7-(((3S)-tetrahydro-3-furanyl)oxy)-6-quinazolinyl)-4-(dimethylamino)-,(2E)-, (2Z)-2-Butenedioate (1:2); Afatinib (diMaleate); Afatinib dimaleate [USAN]; Afatinib maleate (JAN); (S,E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide dimaleate; Afatinib (BIBW2992) Dimaleate; Afatinib dimaleate (USAN); (Z)-but-2-enedioic acid;(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide; AFATINIB MALEATE [JAN]; C32H33ClFN5O11; MFCD25974239; (2E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydrofuran-3-yl)oxy)quinazolin- 6-yl)-4-(dimethylamino)but-2-enamide bis(hydrogen (2Z)-but-2-enedioate); UNII-V1T5K7RZ0B; 850140-73-7 (dimaleate); Gilotrif (TN); (2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide (2Z)-2-butenedioate (1:2) (9CI); Afatinib dimaleate; BIBW 2992MA2; Giotrif (TN); EX-A065B; orb1223861; orb1307469; AFATINIB DIMALEATE [MI]; CHEMBL2105712; SCHEMBL29356586; SCHEMBL29686662; SCHEMBL29838796; USNRYVNRPYXCSP-JUGPPOIOSA-N; AFATINIB DIMALEATE [VANDF]; GLXC-90167; AFATINIB DIMALEATE [WHO-DD]; HY-10261A; AKOS025401819; CCG-270401; CS-1329; AFATINIB DIMALEATE [ORANGE BOOK]; BIBW2992-MA2 (Afatinib dimaleate)?; 1644565-87-6; AC-26080; AS-56967; BA162012; SY059073; D09733; F798908; Q27145677; (2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[(3S)-tetrahydrofuran-3-yloxy]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide di[(2Z)-but-2-enedioate]; (E)-4-Dimethylamino-But-2-Enoic Acid-(4-(3-Chloro-4-Fluoro-Phenylamino)-7-((S)-Tetra-Hydrofuran-3-Yloxy)-Quinazolin-6Yl)-Amide Dimaleate; (E)-N-[4-(3-chloro-4-fluoro-anilino)-7-[(3S)-tetrahydrofuran-3-yl]oxy-quinazolin-6-yl]-4-(dimethylamino)but-2-enamide;maleic acid; (E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(S)-tetrahydrofuran-3-yl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide Dimaleate; 2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydro-3-furanyl)oxy)- 6-quinazolinyl)-4-(dimethylamino)-, (2E)-, (2Z)-2-butenedioate (1:2); 2-butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydro-3-furanyl)oxy)-6-quinazolinyl)-4-(dimethylamino)-, (2e)-, (2Z)-2-butenedioate (1:2); 2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-, (2E)-, (2Z)-2-butenedioate (1:2) (9CI)別名
Afatinib Dimaleateを含む製品
지오트립정40밀리그램(아파티닙이말레산염)지오트립정30밀리그램(아파티닙이말레산염)지오트립정20밀리그램(아파티닙이말레산염)GIOTRIF 50 mg, comprimé pelliculéGIOTRIF 40 mg, comprimé pelliculéGIOTRIF 30 mg, comprimé pelliculéGIOTRIF 20 mg, comprimé pelliculéBIBW2992 DiMaleateAfatinib diMaleateAfatinib DiMaleateAfatinib dimaleateAfatinib Dimaleate
1/2ページ
Afatinib Dimaleateを販売する企業
SF
Shanghai Famo Biotechnology Co.,Ltd.ChinaHD
Hangzhou Dingyan Chem Co., LtdChinaAH
Anhui Haikang Pharmaceutical Co., Ltd.ChinaSS
Shandong Sihuan Pharmaceutical Co.,Ltd.ChinaBI
BOEHRINGER INGELHEIM INTERNATIONALFrance한국
한국베링거인겔하임(주)Republic of KoreaBS
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.ChinaAC
AFINE CHEMICALS LIMITED